The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: Current best estimates

Harrison Graham Pope · Gen Kanayama · Alison J. Athey · Erin Ryan · James I. Hudson · Aaron Leigh Baggish

308 citations0/0 files storedAmerican Journal on Addictions

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Doping in Sports Substance Abuse Treatment and Outcomes Hormonal and reproductive studies

Abstract

BACKGROUND AND OBJECTIVES: Although various surveys have tracked the prevalence of anabolic-androgenic steroid (AAS) use in American teenagers and young adults, no recent surveys have assessed the lifetime prevalence of AAS use in Americans overall. We therefore analyzed serial youth-survey data to derive estimates of the lifetime prevalence of AAS use in the current American general population. METHODS: We first determined the distribution of age of onset of AAS use, based on pooled data from nine studies. Using this distribution, we then developed equations to project the eventual lifetime prevalence of AAS use among young survey respondents, once they aged and completed the period of risk for initiating AAS. We similarly calculated the denominator of lifetimes of risk for AAS use in the total American population. We next applied these equations to four independent national youth datasets to derive current American general-population estimates for lifetime AAS use. Finally, using data from 10 pooled studies, we estimated the lifetime prevalence of AAS dependence among AAS users. RESULTS: Age-of-onset studies consistently showed that AAS use begins later than most drugs, with only 22% of users (95% confidence interval: 19-25%) starting before age 20. Applying the age-of-onset findings to national youth datasets, we estimated that among Americans currently age 13-50 years, 2.9-4.0 million have used AAS. Within this group, roughly 1 million may have experienced AAS dependence. CONCLUSIONS AND SCIENTIFIC SIGNIFICANCE: Although subject to various limitations, our estimation techniques suggest a surprisinigly high prevalence of AAS use and dependence among Americans.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 308 citations exist upstream.

References

1986Meta-analysis in clinical trials 1988Diagnostic and Statistical Manual of Mental Disorders 2001The Adonis Complex: The Secret Crisis of Male Body Obsession 1994Psychiatric and Medical Effects of Anabolic-Androgenic Steroid Use 1999Evolving ideals of male body image as seen through action toys 2006Anabolic Androgenic Steroids

Cited by

2014Anabolic-androgenic Steroid use and Psychopathology in Athletes. A Systematic Review 2017History and epidemiology of anabolic androgens in athletes and non-athletes 2016Muscle Dysmorphia Symptomatology and Associated Psychological Features in Bodybuilders and Non-Bodybuilder Resistance Trainers: A Systematic Review and Meta-Analysis 2019The emergence of Exercise Addiction, Body Dysmorphic Disorder, and other image-related psychopathological correlates in fitness settings: A cross sectional study 2016Anabolic steroid use and body image psychopathology in men: Delineating between appearance- versus performance-driven motivations 2020Anabolic-Androgenic Steroid Use and Body Image in Men: A Growing Concern for Clinicians 2020

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.